A recent study published by the University of Colorado School of Medicine found that low third-party reimbursement rates hamper otherwise effective school-based influenza vaccination programs.
The study, published in the May-June 2014 issue of American Pediatrics, examined a public school in Denver, Colo., that was successful in vaccinating one third of its students but faced significant problems in billing and administration.
The study concluded that while the cost and implementation of school-based vaccine programs was possible and logical, they could not be financially solvent without improved reimbursement delivery.
"Preventing influenza in school-age children is an important deterrent to community-wide epidemics," Allison Kempe, the lead author of the study, said. "That's why school-based influenza vaccination is an ideal testing ground for the development of collaborations within a community."
A second study published by Kempe in American Pediatrics found that parental support exists for school-based influenza vaccination, though parents prefer to be present when the vaccine is delivered.
"Our data demonstrate substantial parental support for the participation of schools in helping accomplish universal coverage among elementary children, although some will likely not participate unless they are allowed to be present for the vaccination of their child," the report said.